Results 121 to 130 of about 10,881,082 (299)
[Objective] To investigate the effects of different storage temperatures and durations on the activities of coagulation factor Ⅷ (Factor Ⅷ, FⅧ) and coagulation factor Ⅸ (Factor Ⅸ, FⅨ) after whole blood collection, so as to provide data support for the ...
WANG Hehe+8 more
doaj +1 more source
TRAUMATIC LESION OF LEFT HEMISPHERE—RIGHT BRACHIO-FACIAL PARALYSIS—APHASIA—ANTISEPTIC TREATMENT—RECOVERY [PDF]
William MacCormac
openalex +1 more source
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song+11 more
wiley +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
Background With China’s economic transformation, essential service workers have become a crucial workforce in tertiary industry. These workers face significant occupational health risks, making occupational health literacy (OHL) vital for their health ...
Shanyu Zhou+6 more
doaj +1 more source
The LETTSOMIAN LECTURES on the CONDITIONS which MODIFY the CHARACTERS of INFLAMMATIONS of the SKIN, and their INFLUENCE on TREATMENT: Delivered before the Medical Society of London [PDF]
H. R. Crocker
openalex +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source